Dr. Nida Ali, MD

Dr. Ali practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Ali's NPI, 1881075646, was assigned on June 17, 2015. Dr. Ali graduated from Dow University of Health Sciences in 2008. Dr. Ali holds California license A156233.

Dr. Ali's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Ali's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is TeleMed2U. Dmand AI also links Dr. Ali to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ali practices. Vendor and product names are available with a free account.

Rheumatology is Dr. Ali's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Ali is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Ali's licenses on file in 2 states: California and Missouri.

Dmand AI lists arteritis, arthritis, gout, joint pain, lupus, muscle pain, fibromyalgia, and limb pain and rheumatoid arthritis among the conditions Dr. Ali treats.

CMS data shows 37 Medicare services from Dr. Ali across 2 procedure codes in 2024, all of them office visits, for 49 Medicare patients. Medicare paid $3,687 for them. Every service was in an office.

CMS counts 49 Medicare patients who saw Dr. Ali in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have arthritis, and 73% have high blood pressure. 37% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ali's median patient age at 50, with 77% women.

In 2024, Dr. Ali wrote 135 Medicare Part D claims for 33 patients. 48% of them were for generic drugs. CMS names the drug for 58 of them, across 3 drugs with 11 or more claims each, at $81,812 in total drug cost. In 2023, CMS named 78 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Ali for performance year 2024, reported as part of a group. Dr. Ali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ali as offering telehealth.

CMS Open Payments shows 18 general payments to Dr. Ali from 9 drug and device companies from 2016 to 2025. Education make up the largest share, 59% of the total. Janssen Pharmaceuticals, Inc paid the most, $297.

Dr. Ali graduated from Dow University of Health Sciences in 2008.

Dr. Ali is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.